Journal Logo

Articles by Stephen MacMahon

68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL

Hata, Jun; Arima, Hisatomi; Rothwell, Peter M; More

Journal of Hypertension. 30:e21, September 2012.

A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals

Brugts, Jasper J; Isaacs, Aaron; de Maat, Moniek PM; More

Journal of Hypertension. 29(3):509-519, March 2011.

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

Czernichow, Sébastien; Zanchetti, Alberto; Turnbull, Fiona; More

Journal of Hypertension. 29(1):4-16, January 2011.

Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial

Ninomiya, Toshiharu; Zoungas, Sophia; Neal, Bruce; More

Journal of Hypertension. 28(6):1141-1149, June 2010.

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial

Arima, Hisatomi; Anderson, Craig; Omae, Teruo; More

Journal of Hypertension. 28(2):395-400, February 2010.

Show: